The management and course of eosinophilic oesophagitis in Israeli children.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
05 2021
Historique:
revised: 23 11 2020
received: 01 10 2020
accepted: 30 12 2020
pubmed: 3 1 2021
medline: 20 5 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

Eosinophilic oesophagitis (EoE) is a chronic inflammatory oesophageal disease, which has become more recognised in the past decade. We wanted to characterise our patients and review their course of disease and response to treatment. We retrospectively reviewed the medical records of EoE patients from January 2010 to May 2018 in our Gastroenterology Institute. A hundred and two children were included in this study. We investigated the characteristics of patients and the response to three treatment options: proton pump inhibitors, elimination diet and topical steroids. The response to treatment was analysed according to 3 aspects: clinical, endoscopic appearance and histological features. Clinical improvement was noted in 55%, 75% and 87.5% on PPIs, diet and budesonide, respectively. Endoscopic improvement was noted in 38.4%, 51.4% and 65.4% on PPIs, diet and budesonide, respectively. Histological improvement was noted in 43.7%, 62.2% and 88.5% on PPIs, diet and budesonide, respectively. Our findings suggest that Israeli paediatric EoE patients have characteristics that resemble previous reports. Although there is a correlation between symptoms, endoscopic and histological appearance, we cannot rely on patients reports alone, and therefore, repeated endoscopy and biopsies are mandated. Topical steroids seem to be the most effective treatment option.

Identifiants

pubmed: 33386629
doi: 10.1111/apa.15746
doi:

Substances chimiques

Proton Pump Inhibitors 0
Budesonide 51333-22-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1653-1657

Informations de copyright

© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

Alterio T, Cardile S, Trayers C, et al. Eosinophilic esophagitis in children: current knowledge to open new horizons. Scand J Gastroenterol. 2019;54(7):822-829.
Hoofien A, Dias JA, Malamisura M, et al. Pediatric eosinophilic esophagitis: results of the european retrospective pediatric eosinophilic esophagitis registry (RetroPEER). J Pediatr Gastroenterol Nutr. 2019;68(4):552-558.
Markowitz JE, Clayton SB. Eosinophilic esophagitis in children and adults. Gastrointest Endosc Clin N Am. 2018;28(1):59-75.
Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335-358.
Soon IS, Butzner JD, Kaplan GG, et al. Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2013;57(1):72-80.
Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):58.
Teoh T, Koo C, Avinashi V, et al. Characterization of ethnicity among children with eosinophilic esophagitis in British Columbia, Canada. J Allergy Clin Immunol Pract. 2015;3(5):803-804.
Gomez Torrijos E, Gonzalez-Mendiola R, Alvarado M, et al. Eosinophilic esophagitis: review and update. Front Med (Lausanne). 2018;5:247.
Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3-20.e6; quiz 21-2.
Davis BP. Pathophysiology of eosinophilic esophagitis. Clin Rev Allergy Immunol. 2018;55(1):19-42.
O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154(2):333-345.
Miehlke S. Clinical features of eosinophilic esophagitis in children and adults. Best Pract Res Clin Gastroenterol. 2015;29(5):739-748.
Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351(9):940-941.
Straumann A, Katzka DA. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology. 2018;154(2):346-359.
Kim HP, Vance RB, Shaheen NJ, et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988-996.e5.
Dhaliwal J, Tobias V, Sugo E, et al. Eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus. 2014;27(4):340-347.
Munoz-Persy M, Lucendo AJ. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Eur J Pediatr. 2018;177(5):649-663.
Kovačić M, Unić J, Mišak Z, et al. One-year outcomes in children with eosinophilic esophagitis. Esophagus. 2019;16(2):162-167.
Ferguson AE, Mukkada VA. Fulkerson PC pediatric eosinophilic esophagitis endotypes: are we closer to predicting treatment response? Clin Rev Allergy Immunol. 2018;55(1):43-55.

Auteurs

Irit Rosen (I)

Pediatric Gastroenterology & Nutrition institute, Ruth Children's Hospital, Haifa, Israel.
Rambam Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Aos Mahamed (A)

Pediatric Neurology and development center, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.

Jamal Garah (J)

Pediatric Gastroenterology & Nutrition institute, Ruth Children's Hospital, Haifa, Israel.
Rambam Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Ramit Magen-Rimon (R)

Pediatric Gastroenterology & Nutrition institute, Ruth Children's Hospital, Haifa, Israel.
Rambam Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Ron Shaoul (R)

Pediatric Gastroenterology & Nutrition institute, Ruth Children's Hospital, Haifa, Israel.
Rambam Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH